-
Use of an Angiotensin-(1-7) Glycopeptide, to Treat Dementia in Parkinson's Disease
… alpha-synuclein) via its effect on the Renin Angiotensin System in the brain, a system that is associated with cognition enhancement and … followed by other cellular and molecular analyses in multiple brain regions to understand how PNA5 alters …
-
New Report: In 2024, Parkinson’s Disease Cost the U.S. $82.2 Billion, Surpassing Previous Projections
March 26, 2026
… parkinsonisms (including progressive supranuclear palsy, multiple system atrophy and dementia with Lewy bodies), which account for …
-
Get with the Times: Parkinson’s Diagnosis Criteria Catches Up with Latest Understanding
November 23, 2015
… Disease . “We now understand Parkinson’s as a multisystemic disorder affecting all parts of the nervous system, … prognosis, but you mostly treat the alternate conditions [multiple system atrophy (MSA), progressive supranuclear palsy (PSP), etc.] …
-
Brain Networks as Targets of Neurodegeneration in Parkinson’s and Alzheimer’s Diseases
… — to measure the amount and distribution of brain atrophy in both diseases, related to clinical severity. We …
-
High-throughput LRRK2 Ubiquitination Assay
… mechanism for LRRK2. This work will create a measurable system to detect the phosphorylation/ubiquitination of LRRK2 … cycle of LRRK2 modification. Project Goal: Cellular systems are ideal to study the molecular players in a … can be adapted to a multi-well format to enable testing of multiple regulators of LRRK2 phosphorylation at once. Study …
-
Development of a Biomarker Platform for Parkinson’s Disease Using Patient-derived Cells
… addresses this need by developing a unique human cellular system for the early identification and study of … investigator plans to grow skin fibroblasts derived from multiple Parkinson’s patients and age-matched controls and …